Drugs Made In America Acquisition II Corp. (DMII) stock
DMIINasdaqBlank ChecksFiscal year ends December 31Also trades as DMIIR, DMIIU
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.24+0.00 (+0.05%)
Close on Nov 17, 2026Market cap $140.36MP/E –Yield –
Drugs Made In America Acquisition II r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Drugs Made In America Acquisition II
Drugs Made In America Acquisition II has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?